The cohort COVID era ASX IPOs was significantly large, but there were far more dud companies than successes. During 2021, A$13bn in capital was raised and the total value of…
EBR Systems Gains Momentum Ahead of 2026 US Launch
EBR Systems (ASX: EBR) is building serious momentum as it moves closer to a full US commercial launch in 2026. Shares…
Imricor Medical Systems (ASX:IMR) is one of a handful of radiology stocks on the ASX, seeking to emulate the success of Pro Medicus (ASX:PME). There's no shortage of peers including…
FDA approval for ASX health stocks is the dream that just about all emerging companies in the sector are aspiring to. Just over 12 months ago, we predicted that Neuren…